ClinicalTrials.gg
Enrolling by invitationNCT06835309SUIUpdated Feb 19, 2025

Isokinetic Strengthening of Hip Muscles Effect on Pelvic Floor Muscles Function in Females With SUI

An interventional study of Pelvic floor muscles exercises and Pelvic floor muscles exercises and isokinetic strengthening of hip muscles in Isokinetic Strengthening, Pelvic Floor Muscles and Stress Urinary Incontinence (SUI), sponsored by British University In Egypt. Enrolling by invitation at 1 site in Egypt. Open to female participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-02-19.

Sponsored by British University In Egypt · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2025, 1 year 6 months ago, but the record still lists the study as enrolling by invitation.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
Female
01

Study summary

This study will be conducted to investigate the impact of isokinetic strengthening of hip muscles on pelvic floor muscles function in women experiencing stress urinary incontinence Does isokinetic strengthening of hip muscles impact pelvic floor muscles function in women experiencing stress urinary incontinence?

02

Conditions studied

  • Isokinetic Strengthening
  • Pelvic Floor Muscles
  • Stress Urinary Incontinence (SUI)
03

In context

Urinary Incontinence, Stress

671 studies on the registry are indexed under Urinary Incontinence, Stress; 122 are open to participants now.

This study's planned enrollment of 60 is below the median of 69 across 520 interventional studies indexed under Urinary Incontinence, Stress.

Browse Urinary Incontinence, Stress studies →

Lead sponsor

British University In Egypt is the lead sponsor of 69 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients diagnosed with stress urinary incontinence
  • age between 30 and 50 years

Exclusion criteria

Exclusion Criteria:

  • low back pain
  • lower limb muscle pathology and/or joint degeneration
  • cardiovascular, metabolic or pulmonary disease
  • body mass index (BMI) > 30 kg/m2.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Control arm

    Pelvic floor muscles exercises

    Other: Pelvic floor muscles exercises

  • Experimental
    Treatment arm

    Pelvic floor muscles exercises and isokinetic strengthening of hip muscles

    Other: Pelvic floor muscles exercises and isokinetic strengthening of hip muscles

Interventions

  • OtherPelvic floor muscles exercises

    The exercises for strengthening the PFM were 10 contractions of 5 seconds, 15 contractions of 3 seconds, 20 contractions of 2 seconds, 20 contractions of 1 second (equal rest time between contractions), and 5 repetitions of maximum contractions while coughing (1-minute interval).25 The level of difficulty of the exercises throughout the 20 sessions was determined by the patient's position, starting in a supine position, then progressing to a sitting position and, finally, to a standing position

  • OtherPelvic floor muscles exercises and isokinetic strengthening of hip muscles

    The hip muscle strengthening exercise was executed on Biodex multi-joint system isokinetic dynamometer. Muscle tension of the lower limbs was relieved by executing 5-minute warm-up exercises using a cycle ergometer before execution of the isokinetic exercise For each hip muscle group, eight repetitions per set for 4 sets were carried out for a single exercise with a 30 second break between each set. The patient's position were the same positions used in the testing procedure. The exercises were carried out 3 times a week and the hip muscles strength evaluation was conducted after the end of the program intervention

06

What researchers measure

Primary outcomes

  1. Pelvic floor muscle strength

    Perineometry to measure vaginal squeeze pressure (in mm hg) the more the grade, the better the muscle strength and so the less the stress urinary incontinence

    Time frame: 12 weeks

Secondary outcomes

  1. Stress urinary incontinence.

    \- International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) to evaluate the frequency, severity and impact on quality of life) the less the grade, the better the muscle strength and so the less the stress urinary incontinence

    Time frame: 12 weeks

07

Study locations

1 site
  • British University in Egypt
    Cairo, 4914058, Egypt
08

References and documents

Related links

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Apr 2025, 3 months after the start.

Of 232 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's planned 3 months is below that.

Counting every sponsor, half of 277 studies reached it within 20 months; a quarter within 10 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2025
First posted
Feb 19, 2025
StartActual
Jan 23, 2025
Primary completionEst.
Apr 23, 2025
CompletionEst.
May 23, 2025
Last update
Feb 19, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06835309
Lead sponsor
British University In Egypt
Responsible party
Sponsor
First posted
Feb 19, 2025
Start date
Jan 23, 2025
Primary completion
Apr 23, 2025 (estimated)
Completion
May 23, 2025 (estimated)
Last update
Feb 19, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion